Virginia Retirement System’s Enanta Pharmaceuticals ENTA Stock Holding History

Virginia Retirement System’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$540K	Buy	+18,400	New	+$512K	0.01%	705

Other funds holding ENTA

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Virginia Retirement System's ENTA Position: Q1 2016 in Review

Virginia Retirement System opened a new position in Enanta Pharmaceuticals (ENTA) in Q1 2016: 18,400 shares worth $540K. The stake represents 0.01% of the portfolio and ranks #705 among its holdings.

152 funds tracked by Wall St. Rank hold ENTA as of Q1 2016.

Virginia Retirement System held 18,400 shares of Enanta Pharmaceuticals worth $540K as of Q1 2016.
Enanta Pharmaceuticals was a new Virginia Retirement System position in Q1 2016.
Enanta Pharmaceuticals made up 0.01% of Virginia Retirement System's portfolio in Q1 2016, its #705 holding.
152 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2016.

Based on Virginia Retirement System's 13F filing for Q1 2016, filed 29 Apr 2016.